Law360, New York (December 16, 2014, 7:32 PM EST) -- The Centers for Medicare and Medicaid Services on Monday injected fresh confusion into its Open Payments program, seeming to contradict a recent regulation by suggesting that drug and device makers may have to disclose many payments to medical education groups.
New agency guidance covers certain payments that manufacturers and group purchasing organizations give to continuing medical education suppliers, which in turn pass some of that money to doctors as speaking fees. Under the guidance, manufacturers would have to disclose certain payments if they learn the identity of paid speakers during a reporting year or within the first half of a subsequent...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!